Growing community of inventors

Rowayton, CT, United States of America

Peter Laivins

Average Co-Inventor Count = 7.00

ph-index = 6

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 71

Peter LaivinsVictor Mandla Moyo (8 patents)Peter LaivinsClet Niyikiza (8 patents)Peter LaivinsJonathan Basil Fitzgerald (8 patents)Peter LaivinsEliel Bayever (8 patents)Peter LaivinsNavreet Dhindsa (8 patents)Peter LaivinsJaeyeon Kim (8 patents)Peter LaivinsPeter Laivins (8 patents)Victor Mandla MoyoVictor Mandla Moyo (43 patents)Clet NiyikizaClet Niyikiza (37 patents)Jonathan Basil FitzgeraldJonathan Basil Fitzgerald (19 patents)Eliel BayeverEliel Bayever (9 patents)Navreet DhindsaNavreet Dhindsa (8 patents)Jaeyeon KimJaeyeon Kim (8 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Merrimack Pharmaceuticals, Inc. (4 from 52 patents)

2. Ipsen Biopharm Limited (4 from 41 patents)


8 patents:

1. 12364691 - Methods for treating pancreatic cancer using combination therapies

2. 11369597 - Methods for treating pancreatic cancer using combination therapies

3. 10980795 - Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan

4. 9717724 - Methods for treating pancreatic cancer using combination therapies

5. 9492442 - Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan

6. 9452162 - Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan

7. 9364473 - Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan

8. 9339497 - Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/5/2025
Loading…